Keywords: halts, topamax, obesity, trials, johnson, halted, clinical

J&J halts Topamax obesity trials

Article | 11 February 2002

Print This

Johnson & Johnson has halted clinical trials of its antiepileptic drugTopamax (topiramate) as a treatment for obesity, on the grounds that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in